Literature DB >> 9796757

Melatonin's role as an anticonvulsant and neuronal protector: experimental and clinical evidence.

A Muñoz-Hoyos1, M Sánchez-Forte, A Molina-Carballo, G Escames, E Martin-Medina, R J Reiter, J A Molina-Font, D Acuña-Castroviejo.   

Abstract

The pineal gland classically has been considered as a vestigial and mystic organ. In the last decades, and with the incorporation of new methodologic procedures, it could be proved that it also has physiologic actions that vary depending on the level of the phylogenetic scale. Its best-known secretion, melatonin, has been related to many different actions, such as sleep promotion, control of biologic rhythms, hormonal inhibition, and an inhibiting action on central nervous system regulation mechanisms. In animal experimentation, there are papers even accepting an anticonvulsant effect. In humans, evidence is reduced to few experiences. In addition to this clinical experience, there is other evidence that clearly relates melatonin to convulsive phenomena. This relationship must be mediated by the following mechanisms attributed to melatonin: altered brain GABAergic neurotransmission, its known interaction with benzodiazepinic brain receptors, through tryptophan metabolite activity (kynurenine, kynurenic acid), or even by its efficacy as a free-radical scavenger.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9796757     DOI: 10.1177/088307389801301007

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  13 in total

1.  Melatonin supplementation for the treatment of infantile spasms: protocol for a randomised placebo-controlled triple-blind trial.

Authors:  Yulin Sun; Weiwei Feng; Jian Chen; Miao Liu; Xiuyu Shi; Jing Wang; Liping Zou; Tao Xu; Guang Yang
Journal:  BMJ Open       Date:  2022-07-04       Impact factor: 3.006

Review 2.  Melatonin's Benefits and Risks as a Therapy for Sleep Disturbances in the Elderly: Current Insights.

Authors:  Daniel P Cardinali; Gregory M Brown; Seithikurippu R Pandi-Perumal
Journal:  Nat Sci Sleep       Date:  2022-10-14

Review 3.  Does melatonin affect epileptic seizures?

Authors:  Siddharth Jain; Frank M C Besag
Journal:  Drug Saf       Date:  2013-04       Impact factor: 5.606

Review 4.  Melatonin as add-on treatment for epilepsy.

Authors:  Francesco Brigo; Stanley C Igwe; Alessandra Del Felice
Journal:  Cochrane Database Syst Rev       Date:  2016-08-11

Review 5.  Melatonin for cognitive impairment.

Authors:  S L Jansen; D A Forbes; V Duncan; D G Morgan
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

6.  Neurotoxins: free radical mechanisms and melatonin protection.

Authors:  Russel J Reiter; Lucien C Manchester; Dun-Xian Tan
Journal:  Curr Neuropharmacol       Date:  2010-09       Impact factor: 7.363

7.  Clinical uses of melatonin in pediatrics.

Authors:  Emilio J Sánchez-Barceló; Maria D Mediavilla; Russel J Reiter
Journal:  Int J Pediatr       Date:  2011-06-16

Review 8.  Analgesic, anxiolytic and anaesthetic effects of melatonin: new potential uses in pediatrics.

Authors:  Lucia Marseglia; Gabriella D'Angelo; Sara Manti; Salvatore Aversa; Teresa Arrigo; Russel J Reiter; Eloisa Gitto
Journal:  Int J Mol Sci       Date:  2015-01-06       Impact factor: 5.923

Review 9.  Melatonin for the Management of Preeclampsia: A Review.

Authors:  Annie Langston-Cox; Sarah A Marshall; Daisy Lu; Kirsten R Palmer; Euan M Wallace
Journal:  Antioxidants (Basel)       Date:  2021-03-03

Review 10.  Neuroprotection by radical avoidance: search for suitable agents.

Authors:  Rüdiger Hardeland
Journal:  Molecules       Date:  2009-12-07       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.